Siraliden en es it fr


Siraliden Marchi, Siraliden Analoghi

Siraliden Marchi miscela

  • No information avaliable
  • Siraliden Formula chimica


    Siraliden RX link

    Siraliden FDA foglio

    Siraliden DMS (foglio di materiale di sicurezza)

    Siraliden MSDS

    Siraliden Sintesi di riferimento

    Nessuna informazione disponibile

    Siraliden Peso molecolare

    238.157 g/mol

    Siraliden Temperatura di fusione

    263 oC

    Siraliden H2O Solubilita

    79,5 mg / L

    Siraliden Stato


    Siraliden LogP


    Siraliden Forme di dosaggio


    Siraliden Indicazione

    Per il trattamento delle infezioni del tratto urinario

    Siraliden Farmacologia

    Nitrofurantoina, un agente antibatterico nitrofurano, รจ disponibile in forma microcristallina e macrocrystalline nel trattamento delle infezioni del tratto urinario causata da molti batteri gram-negativi e alcuni batteri gram-positivi.

    Siraliden Assorbimento

    Nessuna informazione disponibile

    Siraliden Tossicita

    Nessuna informazione disponibile

    Siraliden Informazioni paziente

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Siraliden Atto interessato organismi

    Gram negativi e alcuni batteri gram-positivi